Bright Minds Biosciences (TSE:DRUG) has released an update.
Bright Minds Biosciences Inc. reported a net and comprehensive loss of $2,028,505 for the nine months ended June 30, 2024, with a decrease in total assets from $6,879,072 in 2023 to $6,277,871 in 2024. The shareholders’ equity also saw a reduction from $6,598,216 in the previous year to $6,099,243, reflecting ongoing financial challenges for the company.
For further insights into TSE:DRUG stock, check out TipRanks’ Stock Analysis page.
